Structure and functional roles of Epac2 (Rapgef4)

Gene

Volumn 575, Issue 2, 2016, Pages 577-583

  Sugawara, Kenji ^a   Shibasaki, Tadao ^a   Takahashi, Harumi ^a   Seino, Susumu ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cAMP; Epac2; Rap

Indexed keywords

ANTIPORTER; CYCLIC AMP; EXCHANGE PROTEIN ACTIVATED BY CYCLIC AMP 2; GLUCAGON; INSULIN; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAPGEF4 PROTEIN, HUMAN; RAS PROTEIN;

BRAIN DEVELOPMENT; BRAIN FUNCTION; GENE; GENE FUNCTION; GENE STRUCTURE; GENE TARGETING; GLUCAGON RELEASE; HEART; HUMAN; INSULIN RELEASE; MOLECULAR PATHOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAPGEF4 GENE; REVIEW; ANIMAL; BRAIN; CHEMISTRY; ENDOCRINE SYSTEM; HEART MUSCLE; METABOLISM; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CYCLIC AMP; ENDOCRINE SYSTEM; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MYOCARDIUM; PROTEIN CONFORMATION; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84948799297     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.09.029     Document Type: Review

References (98)

1. Ahren, B., Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug Discov. 8 (2009), 369–385.
2. Bacchelli, E., Blasi, F., Biondolillo, M., Lamb, J.A., Bonora, E., Barnby, G., Parr, J., Beyer, K.S., Klauck, S.M., Poustka, A., Bailey, A.J., Monaco, A.P., Maestrini, E., Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol. Psychiatry 8 (2003), 916–924.
3. 2 + channels accounts for first-phase insulin secretion in mouse beta-cells. Diabetes 51:Suppl. 1 (2002), S74–S82.
4. Baukrowitz, T., Schulte, U., Oliver, D., Herlitze, S., Krauter, T., Tucker, S.J., Ruppersberg, J.P., Fakler, B., PIP2 and PIP as determinants for ATP inhibition of KATP channels. Science 282 (1998), 1141–1144.
5. Beavo, J.A., Brunton, L.L., Cyclic nucleotide research — still expanding after half a century. Nat. Rev. Mol. Cell Biol. 3 (2002), 710–718.
6. Bers, D.M., Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 70 (2008), 23–49.
7. Bos, J.L., Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31 (2006), 680–686.
8. Bratanova-Tochkova, T.K., Cheng, H., Daniel, S., Gunawardana, S., Liu, Y.J., Mulvaney-Musa, J., Schermerhorn, T., Straub, S.G., Yajima, H., Sharp, G.W., Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 51:Suppl. 1 (2002), S83–S90.
9. Christensen, A.E., Selheim, F., de Rooij, J., Dremier, S., Schwede, F., Dao, K.K., Martinez, A., Maenhaut, C., Bos, J.L., Genieser, H.G., Doskeland, S.O., cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278 (2003), 35394–35402.
10. Consonni, S.V., Gloerich, M., Spanjaard, E., Bos, J.L., cAMP regulates DEP domain-mediated binding of the guanine nucleotide exchange factor Epac1 to phosphatidic acid at the plasma membrane. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3814–3819.
11. Curry, D.L., Bennett, L.L., Grodsky, G.M., Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 83 (1968), 572–584.
12. de Heer, J., Rasmussen, C., Coy, D.H., Holst, J.J., Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 51 (2008), 2263–2270.
13. 2 + channel-dependent exocytosis. Cell Metab. 11 (2010), 543–553.
14. de Rooij, J., Rehmann, H., van Triest, M., Cool, R.H., Wittinghofer, A., Bos, J.L., Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J. Biol. Chem. 275 (2000), 20829–20836.
15. de Rooij, J., Zwartkruis, F.J., Verheijen, M.H., Cool, R.H., Nijman, S.M., Wittinghofer, A., Bos, J.L., Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998), 474–477.
16. Drucker, D.J., The biology of incretin hormones. Cell Metab. 3 (2006), 153–165.
17. Dzhura, I., Chepurny, O.G., Kelley, G.G., Leech, C.A., Roe, M.W., Dzhura, E., Afshari, P., Malik, S., Rindler, M.J., Xu, X., Lu, Y., Smrcka, A.V., Holz, G.G., Epac2-dependent mobilization of intracellular Ca(2)+ by glucagon-like peptide-1 receptor agonist exendin-4 is disrupted in beta-cells of phospholipase C-epsilon knockout mice. J. Physiol. 588 (2010), 4871–4889.
18. Dzhura, I., Chepurny, O.G., Leech, C.A., Roe, M.W., Dzhura, E., Xu, X., Lu, Y., Schwede, F., Genieser, H.G., Smrcka, A.V., Holz, G.G., Phospholipase C-epsilon links Epac2 activation to the potentiation of glucose-stimulated insulin secretion from mouse islets of Langerhans. Islets 3 (2011), 121–128.
19. El-Armouche, A., Eschenhagen, T., Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail. Rev. 14 (2009), 225–241.
20. Emery, A.C., Eiden, M.V., Eiden, L.E., Separate cyclic AMP sensors for neuritogenesis, growth arrest, and survival of neuroendocrine cells. J. Biol. Chem. 289 (2014), 10126–10139.
21. Enserink, J.M., Christensen, A.E., de Rooij, J., van Triest, M., Schwede, F., Genieser, H.G., Doskeland, S.O., Blank, J.L., Bos, J.L., A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 4 (2002), 901–906.
22. Fernandes, H.B., Riordan, S., Nomura, T., Remmers, C.L., Kraniotis, S., Marshall, J.J., Kukreja, L., Vassar, R., Contractor, A., Epac2 mediates cAMP-dependent potentiation of neurotransmission in the hippocampus. J. Neurosci. 35 (2015), 6544–6553.
23. Frische, E.W., Zwartkruis, F.J., Rap1, a mercenary among the Ras-like GTPases. Dev. Biol. 340 (2010), 1–9.
24. Fu, D., Wakabayashi, Y., Lippincott-Schwartz, J., Arias, I.M., Bile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 1403–1408.
25. 2 + sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis. J. Biol. Chem. 277 (2002), 50497–50502.
26. Gekel, I., Neher, E., Application of an Epac activator enhances neurotransmitter release at excitatory central synapses. J. Neurosci. 28 (2008), 7991–8002.
27. Gelinas, J.N., Banko, J.L., Peters, M.M., Klann, E., Weeber, E.J., Nguyen, P.V., Activation of exchange protein activated by cyclic-AMP enhances long-lasting synaptic potentiation in the hippocampus. Learn. Mem. 15 (2008), 403–411.
28. Gloerich, M., Bos, J.L., Regulating Rap small G-proteins in time and space. Trends Cell Biol. 21 (2011), 615–623.
29. Gromada, J., Dissing, S., Bokvist, K., Renstrom, E., Frokjaer-Jensen, J., Wulff, B.S., Rorsman, P., Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization. Diabetes 44 (1995), 767–774.
30. Henquin, J.C., Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49 (2000), 1751–1760.
31. Hoivik, E.A., Witsoe, S.L., Bergheim, I.R., Xu, Y., Jakobsson, I., Tengholm, A., Doskeland, S.O., Bakke, M., DNA methylation of alternative promoters directs tissue specific expression of Epac2 isoforms. PLoS One, 8, 2013, e67925.
32. Holz, G.G., Kang, G., Harbeck, M., Roe, M.W., Chepurny, O.G., Cell physiology of cAMP sensor Epac. J. Physiol. 577 (2006), 5–15.
33. 2 + signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). J. Biol. Chem. 274 (1999), 14147–14156.
34. Hothi, S.S., Gurung, I.S., Heathcote, J.C., Zhang, Y., Booth, S.W., Skepper, J.N., Grace, A.A., Huang, C.L., Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pflugers Arch. 457 (2008), 253–270.
35. Kai, A.K., Lam, A.K., Chen, Y., Tai, A.C., Zhang, X., Lai, A.K., Yeung, P.K., Tam, S., Wang, J., Lam, K.S., Vanhoutte, P.M., Bos, J.L., Chung, S.S., Xu, A., Chung, S.K., Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop beta-cell dysfunction and metabolic syndrome. FASEB J. 27 (2013), 4122–4135.
36. 2 + release in INS-1 pancreatic beta-cells. J. Physiol. 536 (2001), 375–385.
37. Kang, G., Chepurny, O.G., Malester, B., Rindler, M.J., Rehmann, H., Bos, J.L., Schwede, F., Coetzee, W.A., Holz, G.G., cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS-1 cells. J. Physiol. 573 (2006), 595–609.
38. 2 + release and exocytosis in pancreatic beta-cells. J. Biol. Chem. 278 (2003), 8279–8285.
39. Kashima, Y., Miki, T., Shibasaki, T., Ozaki, N., Miyazaki, M., Yano, H., Seino, S., Critical role of cAMP-GEFII–Rim2 complex in incretin-potentiated insulin secretion. J. Biol. Chem. 276 (2001), 46046–46053.
40. Kawasaki, H., Springett, G.M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D.E., Graybiel, A.M., A family of cAMP-binding proteins that directly activate Rap1. Science 282 (1998), 2275–2279.
41. Kelley, G.G., Reks, S.E., Ondrako, J.M., Smrcka, A.V., Phospholipase C(epsilon): a novel Ras effector. EMBO J. 20 (2001), 743–754.
42. Kiermayer, S., Biondi, R.M., Imig, J., Plotz, G., Haupenthal, J., Zeuzem, S., Piiper, A., Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells. Mol. Biol. Cell 16 (2005), 5639–5648.
43. Kim, M., Platt, M.J., Shibasaki, T., Quaggin, S.E., Backx, P.H., Seino, S., Simpson, J.A., Drucker, D.J., GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat. Med. 19 (2013), 567–575.
44. Li, Y., Asuri, S., Rebhun, J.F., Castro, A.F., Paranavitana, N.C., Quilliam, L.A., The RAP1 guanine nucleotide exchange factor Epac2 couples cyclic AMP and Ras signals at the plasma membrane. J. Biol. Chem. 281 (2006), 2506–2514.
45. Liu, C., Takahashi, M., Li, Y., Song, S., Dillon, T.J., Shinde, U., Stork, P.J., Ras is required for the cyclic AMP-dependent activation of Rap1 via Epac2. Mol. Cell. Biol. 28 (2008), 7109–7125.
46. Metrich, M., Laurent, A.C., Breckler, M., Duquesnes, N., Hmitou, I., Courillau, D., Blondeau, J.P., Crozatier, B., Lezoualc'h, F., Morel, E., Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway. Cell. Signal. 22 (2010), 1459–1468.
47. Metrich, M., Lucas, A., Gastineau, M., Samuel, J.L., Heymes, C., Morel, E., Lezoualc'h, F., Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ. Res. 102 (2008), 959–965.
48. Montague, W., Howell, S.L., The mode of action of adenosine 3′:5′-cyclic monophosphate in mammalian islets of Langerhans. Preparation and properties of islet-cell protein phosphokinase. Biochem. J. 129 (1972), 551–560.
49. Morel, E., Marcantoni, A., Gastineau, M., Birkedal, R., Rochais, F., Garnier, A., Lompre, A.M., Vandecasteele, G., Lezoualc'h, F., cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ. Res. 97 (2005), 1296–1304.
50. Murray, A.J., Shewan, D.A., Epac mediates cyclic AMP-dependent axon growth, guidance and regeneration. Mol. Cell. Neurosci. 38 (2008), 578–588.
51. Nauck, M.A., Unraveling the science of incretin biology. Am. J. Med. 122 (2009), S3–S10.
52. Niimura, M., Miki, T., Shibasaki, T., Fujimoto, W., Iwanaga, T., Seino, S., Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J. Cell. Physiol. 219 (2009), 652–658.
53. Nijholt, I.M., Dolga, A.M., Ostroveanu, A., Luiten, P.G., Schmidt, M., Eisel, U.L., Neuronal AKAP150 coordinates PKA and Epac-mediated PKB/Akt phosphorylation. Cell. Signal. 20 (2008), 1715–1724.
54. Ostroveanu, A., van der Zee, E.A., Eisel, U.L., Schmidt, M., Nijholt, I.M., Exchange protein activated by cyclic AMP 2 (Epac2) plays a specific and time-limited role in memory retrieval. Hippocampus 20 (2010), 1018–1026.
55. Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., Takai, Y., Seino, S., cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat. Cell Biol. 2 (2000), 805–811.
56. Park, J.H., Kim, S.J., Park, S.H., Son, D.G., Bae, J.H., Kim, H.K., Han, J., Song, D.K., Glucagon-like peptide-1 enhances glucokinase activity in pancreatic beta-cells through the association of Epac2 with Rim2 and Rab3A. Endocrinology 153 (2012), 574–582.
57. Parnell, E., Palmer, T.M., Yarwood, S.J., The future of EPAC-targeted therapies: agonism versus antagonism. Trends Pharmacol. Sci. 36 (2015), 203–214.
58. Penzes, P., Woolfrey, K.M., Srivastava, D.P., Epac2-mediated dendritic spine remodeling: implications for disease. Mol. Cell. Neurosci. 46 (2011), 368–380.
59. 2 + leak and arrhythmia. Circulation 127 (2013), 913–922.
60. Pereira, L., Rehmann, H., Lao, D.H., Erickson, J.R., Bossuyt, J., Chen, J., Bers, D.M., Novel Epac fluorescent ligand reveals distinct Epac1 vs. Epac2 distribution and function in cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 3991–3996.
61. Pereira, L., Ruiz-Hurtado, G., Morel, E., Laurent, A.C., Metrich, M., Dominguez-Rodriguez, A., Lauton-Santos, S., Lucas, A., Benitah, J.P., Bers, D.M., Lezoualc'h, F., Gomez, A.M., Epac enhances excitation-transcription coupling in cardiac myocytes. J. Mol. Cell. Cardiol. 52 (2012), 283–291.
62. Qiao, J., Mei, F.C., Popov, V.L., Vergara, L.A., Cheng, X., Cell cycle-dependent subcellular localization of exchange factor directly activated by cAMP. J. Biol. Chem. 277 (2002), 26581–26586.
63. Quesada, I., Tuduri, E., Ripoll, C., Nadal, A., Physiology of the pancreatic alpha-cell and glucagon secretion: role in glucose homeostasis and diabetes. J. Endocrinol. 199 (2008), 5–19.
64. Rehmann, H., Epac2: a sulfonylurea receptor?. Biochem. Soc. Trans. 40 (2012), 6–10.
65. Rehmann, H., Arias-Palomo, E., Hadders, M.A., Schwede, F., Llorca, O., Bos, J.L., Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455 (2008), 124–127.
66. Rehmann, H., Das, J., Knipscheer, P., Wittinghofer, A., Bos, J.L., Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 439 (2006), 625–628.
67. Renstrom, E., Eliasson, L., Rorsman, P., Protein kinase A-dependent and -independent stimulation of exocytosis by cAMP in mouse pancreatic β-cells. J. Physiol. 502:Pt 1 (1997), 105–118.
68. Roscioni, S.S., Elzinga, C.R., Schmidt, M., Epac: effectors and biological functions. Naunyn Schmiedeberg's Arch. Pharmacol. 377 (2008), 345–357.
69. Sakaba, T., Neher, E., Preferential potentiation of fast-releasing synaptic vesicles by cAMP at the calyx of Held. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 331–336.
70. Sandoval, D.A., D'Alessio, D.A., Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol. Rev. 95 (2015), 513–548.
71. Schmidt, M., Dekker, F.J., Maarsingh, H., Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol. Rev. 65 (2013), 670–709.
72. Schmidt, M., Evellin, S., Weernink, P.A., von Dorp, F., Rehmann, H., Lomasney, J.W., Jakobs, K.H., A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase. Nat. Cell Biol. 3 (2001), 1020–1024.
73. Schwede, F., Bertinetti, D., Langerijs, C.N., Hadders, M.A., Wienk, H., Ellenbroek, J.H., de Koning, E.J., Bos, J.L., Herberg, F.W., Genieser, H.G., Janssen, R.A., Rehmann, H., Structure-guided design of selective Epac1 and Epac2 agonists. PLoS Biol., 13, 2015, e1002038.
74. Seino, S., Shibasaki, T., Minami, K., Dynamics of insulin secretion and the clinical implications for obesity and diabetes. J. Clin. Invest. 121 (2011), 2118–2125.
75. Seino, Y., Fukushima, M., Yabe, D., GIP and GLP-1, the two incretin hormones: similarities and differences. J. Diabetes Investig. 1 (2010), 8–23.
76. 2 + channel in insulin granule exocytosis. J. Biol. Chem. 279 (2004), 7956–7961.
77. Shibasaki, T., Takahashi, H., Miki, T., Sunaga, Y., Matsumura, K., Yamanaka, M., Zhang, C., Tamamoto, A., Satoh, T., Miyazaki, J., Seino, S., Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 19333–19338.
78. Song, C., Satoh, T., Edamatsu, H., Wu, D., Tadano, M., Gao, X., Kataoka, T., Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon. Oncogene 21 (2002), 8105–8113.
79. Srivastava, D.P., Jones, K.A., Woolfrey, K.M., Burgdorf, J., Russell, T.A., Kalmbach, A., Lee, H., Yang, C., Bradberry, M.M., Wokosin, D., Moskal, J.R., Casanova, M.F., Waters, J., Penzes, P., Social, communication, and cortical structural impairments in Epac2-deficient mice. J. Neurosci. 32 (2012), 11864–11878.
80. Srivastava, D.P., Woolfrey, K.M., Jones, K.A., Anderson, C.T., Smith, K.R., Russell, T.A., Lee, H., Yasvoina, M.V., Wokosin, D.L., Ozdinler, P.H., Shepherd, G.M., Penzes, P., An autism-associated variant of Epac2 reveals a role for Ras/Epac2 signaling in controlling basal dendrite maintenance in mice. PLoS Biol., 10, 2012, e1001350.
81. Ster, J., de Bock, F., Bertaso, F., Abitbol, K., Daniel, H., Bockaert, J., Fagni, L., Epac mediates PACAP-dependent long-term depression in the hippocampus. J. Physiol. 587 (2009), 101–113.
82. Takahashi, H., Shibasaki, T., Park, J.H., Hidaka, S., Takahashi, T., Ono, A., Song, D.K., Seino, S., Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion. Diabetes 64 (2015), 1262–1272.
83. Takahashi, T., Shibasaki, T., Takahashi, H., Sugawara, K., Ono, A., Inoue, N., Furuya, T., Seino, S., Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A. Sci. Signal., 6, 2013, ra94.
84. Thorens, B., Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. U. S. A. 89 (1992), 8641–8645.
85. Tsalkova, T., Gribenko, A.V., Cheng, X., Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs. Assay Drug Dev. Technol. 9 (2011), 88–91.
86. 2 + and stimulates mitochondrial ATP synthesis in pancreatic MIN6 beta-cells. Biochem. J. 369 (2003), 287–299.
87. Uenishi, E., Shibasaki, T., Takahashi, H., Seki, C., Hamaguchi, H., Yasuda, T., Tatebe, M., Oiso, Y., Takenawa, T., Seino, S., Actin dynamics regulated by the balance of neuronal Wiskott–Aldrich syndrome protein (N-WASP) and cofilin activities determines the biphasic response of glucose-induced insulin secretion. J. Biol. Chem. 288 (2013), 25851–25864.
88. Ueno, H., Shibasaki, T., Iwanaga, T., Takahashi, K., Yokoyama, Y., Liu, L.M., Yokoi, N., Ozaki, N., Matsukura, S., Yano, H., Seino, S., Characterization of the gene EPAC2: structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform. Genomics 78 (2001), 91–98.
89. Ulucan, C., Wang, X., Baljinnyam, E., Bai, Y., Okumura, S., Sato, M., Minamisawa, S., Hirotani, S., Ishikawa, Y., Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H1662–H1672.
90. Usdin, T.B., Mezey, E., Button, D.C., Brownstein, M.J., Bonner, T.I., Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133 (1993), 2861–2870.
91. Vliem, M.J., Ponsioen, B., Schwede, F., Pannekoek, W.J., Riedl, J., Kooistra, M.R., Jalink, K., Genieser, H.G., Bos, J.L., Rehmann, H., 8-pCPT-2′-O-Me-cAMP-AM: an improved Epac-selective cAMP analogue. Chembiochem 9 (2008), 2052–2054.
92. Wang, Z., Oh, E., Thurmond, D.C., Glucose-stimulated Cdc42 signaling is essential for the second phase of insulin secretion. J. Biol. Chem. 282 (2007), 9536–9546.
93. Woolfrey, K.M., Srivastava, D.P., Photowala, H., Yamashita, M., Barbolina, M.V., Cahill, M.E., Xie, Z., Jones, K.A., Quilliam, L.A., Prakriya, M., Penzes, P., Epac2 induces synapse remodeling and depression and its disease-associated forms alter spines. Nat. Neurosci. 12 (2009), 1275–1284.
94. Yamada, Y., Hayami, T., Nakamura, K., Kaisaki, P.J., Someya, Y., Wang, C.Z., Seino, S., Seino, Y., Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. Genomics 29 (1995), 773–776.
95. Yang, Y., Shu, X., Liu, D., Shang, Y., Wu, Y., Pei, L., Xu, X., Tian, Q., Zhang, J., Qian, K., Wang, Y.X., Petralia, R.S., Tu, W., Zhu, L.Q., Wang, J.Z., Lu, Y., EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation. Neuron 73 (2012), 774–788.
96. Yasuda, T., Shibasaki, T., Minami, K., Takahashi, H., Mizoguchi, A., Uriu, Y., Numata, T., Mori, Y., Miyazaki, J., Miki, T., Seino, S., Rim2alpha determines docking and priming states in insulin granule exocytosis. Cell Metab. 12 (2010), 117–129.
97. Zhang, C.L., Katoh, M., Shibasaki, T., Minami, K., Sunaga, Y., Takahashi, H., Yokoi, N., Iwasaki, M., Miki, T., Seino, S., The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 325 (2009), 607–610.
98. Zhong, N., Zucker, R.S., cAMP acts on exchange protein activated by cAMP/cAMP-regulated guanine nucleotide exchange protein to regulate transmitter release at the crayfish neuromuscular junction. J. Neurosci. 25 (2005), 208–214.